Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 141 (RNA5SP141) is a non-coding RNA pseudogene derived from the 5S ribosomal RNA gene family. Unlike functional 5S rRNA, which is a structural and functional component of the large ribosomal subunit, RNA5SP141 does not contribute to ribosome assembly or protein synthesis[3][5][7]. Instead, its significance is primarily as a ligand for the RIG-I innate immune receptor: during infection by DNA viruses such as herpes simplex virus type 1 (HSV-1), RNA5SP141 is upregulated and relocates from the nucleus to the cytoplasm. In the cytoplasm, it is recognized by RIG-I, triggering a robust interferon-beta (IFN-β) response, and thus contributes to the cellular antiviral defense[2][4][6]. Under normal conditions, RNA5SP141 is shielded and not detected by RIG-I, but viral-induced changes expose it to immune sensing. It is not a receptor, enzyme, transporter, or a transcription factor, and currently has no known disease roles outside virus-host interactions, no known drugs or biomarkers, and is not the subject of therapeutic interventions[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 141 (RNA5SP141).